1. Improved metabolic parameters of people with diabetes attending an Aboriginal health service in regional Victoria.
- Author
-
Eer, Audrey S., Hearn, Tracey, Atkinson‐Briggs, Sharon, Drake, Shannon, Singh, Satpal, Neoh, Sandra, Pyrlis, Felicity, Hachem, Mariam, Zajac, Jeffrey D., Burchill, Luke J., O'Brien, Richard C., and Ekinci, Elif I.
- Subjects
INDIGENOUS Australians ,GLYCOSYLATED hemoglobin ,OBESITY ,BIOCHEMISTRY ,ALBUMINS ,HEALTH services accessibility ,HEMOGLOBINS ,KIDNEY function tests ,ANTILIPEMIC agents ,AGE distribution ,GLYCEMIC control ,ACE inhibitors ,HYPOGLYCEMIC agents ,TYPE 2 diabetes ,COMPARATIVE studies ,SYMPTOMS ,PLATELET aggregation inhibitors ,BODY mass index ,VASCULAR diseases ,BLOOD pressure measurement ,SECONDARY care (Medicine) ,MEDICAL care of indigenous peoples ,MEDICAL specialties & specialists ,LIPIDS ,CREATININE ,DISEASE complications - Abstract
Background: Aboriginal and Torres Strait Islander people have higher rates of diabetes and its complications than non‐Aboriginal people. Rumbalara Aboriginal Co‐operative is the major primary healthcare provider for Aboriginal people in the Greater Shepparton region. Aims: To evaluate the baseline metabolic parameters and presence of diabetes complications in people with type 2 diabetes attending Rumbalara Aboriginal Co‐operative in 2017 and compare it with other Aboriginal and Torres Strait Islander studies and Australian specialist diabetes services. Methods: Clinical and biochemical characteristics, including diabetes type, age, weight, body mass index (BMI), blood pressure, micro‐ and macrovascular complications, glycosylated haemoglobin (HbA1c), haemoglobin, renal function, lipid profile, urine albumin:creatinine ratio, diabetes medications, renin angiotensin system inhibition therapies, HMG‐CoA reductase inhibitors and antiplatelet agents, were determined. Results: One hundred and twenty‐six individuals had diabetes, 121 had type 2 diabetes. One hundred and thirteen identified as Aboriginal and/or Torres Strait Islander. Median age was 57.5 (48–68) years, median HbA1c was 7.8% (6.8–9.6) and median BMI was 33.4 kg/m2 (29–42.3). Compared with other Australian Aboriginal and Torres Strait Islander populations, this population was older and had more obesity, but with better glycaemia management. Compared with specialist diabetes services, this population was of similar age, with greater BMI but comparable HbA1c. Conclusions: Aboriginal people living with type 2 diabetes attending this regional Aboriginal health service have comparable glycaemic management to specialist diabetes services in Australia, managed largely by primary care physicians with limited access to specialist care for the past 5 years. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF